Algernon Health Announces Effective Date of Previously Announced Name Change to "Grey Matters Health Inc." and its 10:1 Share Consolidation
Algernon Health Announces Proposed Name Change to "Grey Matters Health Inc." and a 10:1 Share Consolidation
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement
Algernon CEO and CSO to Discuss New DMT Stroke Clinical Research Program Featured on BioPub Webcast Hosted by Dr. KSS MD, PhD
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT "The Spirit Molecule"
Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment
Total Metals Acquires 100% Interest in the High-Grade Pick Lake Critical Minerals Property from Frontier Energy Limited
Generation Uranium Defines Multiple High-Impact Drill Targets At Yath Project, Leveraging Proven Discovery Model In One of Canada's Hottest Uranium Districts
SAGA Metals Executes Title Transfer Agreement to Expand Wolverine Heavy Rare Earth Element Project in Labrador-Grab Sample Assays Included up to 21.6% TREO
Metalsource Mining Intersects 1.1kg/t AgEq over 3.1m, Continues Identifying Widespread Polymetallic Mineralization While Expanding the Dip Length of the System Approximately 260m from Surface
